Lymphangiogenesis and lymphatic vessel remodelling in cancer

被引:628
作者
Stacker, Steven A. [1 ,2 ,3 ]
Williams, Steven P. [1 ]
Karnezis, Tara [1 ,2 ]
Shayan, Ramin [1 ,3 ,4 ,5 ]
Fox, Stephen B. [6 ]
Achen, Marc G. [1 ,2 ,3 ]
机构
[1] Peter MacCallum Canc Ctr, Tumour Angiogenesis Program, East Melbourne, Vic 3002, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3010, Australia
[3] Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3050, Australia
[4] Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia
[5] Australian Catholic Univ, OBrien Inst, Fitzroy, Vic 3065, Australia
[6] Peter MacCallum Canc Ctr, Dept Pathol, East Melbourne, Vic 3002, Australia
基金
英国医学研究理事会;
关键词
ENDOTHELIAL-GROWTH-FACTOR; CELL LUNG-CANCER; PROMOTES TUMOR-METASTASIS; VEGF-D PROMOTES; VASCULAR NETWORK FORMATION; CHEMOKINE RECEPTOR CXCR4; I COLORECTAL-CARCINOMA; HUMAN BREAST-CANCER; FACTOR-C EXPRESSION; NODE METASTASIS;
D O I
10.1038/nrc3677
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The generation of new lymphatic vessels through lymphangiogenesis and the remodelling of existing lymphatics are thought to be important steps in cancer metastasis. The past decade has been exciting in terms of research into the molecular and cellular biology of lymphatic vessels in cancer, and it has been shown that the molecular control of tumour lymphangiogenesis has similarities to that of tumour angiogenesis. Nevertheless, there are significant mechanistic differences between these biological processes. We are now developing a greater understanding of the specific roles of distinct lymphatic vessel subtypes in cancer, and this provides opportunities to improve diagnostic and therapeutic approaches that aim to restrict the progression of cancer.
引用
收藏
页码:159 / 172
页数:14
相关论文
共 201 条
  • [1] Targeting lymphangiogenesis to prevent tumour metastasis
    Achen, M. G.
    Mann, G. B.
    Stacker, S. A.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (10) : 1355 - 1360
  • [2] Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3
    Achen, MG
    Roufail, S
    Domagala, T
    Catimel, B
    Nice, EC
    Geleick, DM
    Murphy, R
    Scott, AM
    Caesar, C
    Makinen, T
    Alitalo, K
    Stacker, SA
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (09): : 2505 - 2515
  • [3] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
    Achen, MG
    Jeltsch, M
    Kukk, E
    Mäkinen, T
    Vitali, A
    Wilks, AF
    Alitalo, K
    Stacker, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 548 - 553
  • [4] Focus on lymphangiogenesis in tumor metastasis
    Achen, MG
    McColl, BK
    Stacker, SA
    [J]. CANCER CELL, 2005, 7 (02) : 121 - 127
  • [5] Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases
    Adachi, Yoshin
    Nakamura, Hiroshige
    Kitamura, Yukisato
    Taniguchi, Yuji
    Araki, Kunio
    Shomori, Kohei
    Horie, Yasushi
    Kurozawa, Youichi
    Ito, Hisao
    Hayashi, Kazuhiko
    [J]. PATHOLOGY INTERNATIONAL, 2007, 57 (04) : 171 - 177
  • [6] Lymphangiogenesis does not occur in breast cancer
    Agarwal, B
    Saxena, R
    Morimiya, A
    Mehrotra, S
    Badve, S
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (11) : 1449 - 1455
  • [7] Akagi Y, 2013, ANTICANCER RES, V33, P2965
  • [8] Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth
    Albuquerque, Romulo J. C.
    Hayashi, Takahiko
    Cho, Won Gil
    Kleinman, Mark E.
    Dridi, Sami
    Takeda, Atsunobu
    Baffi, Judit Z.
    Yamada, Kiyoshi
    Kaneko, Hiroki
    Green, Martha G.
    Chappell, Joe
    Wilting, Joerg
    Weich, Herbert A.
    Yamagami, Satoru
    Amano, Shiro
    Mizuki, Nobuhisa
    Alexander, Jonathan S.
    Peterson, Martha L.
    Brekken, Rolf A.
    Hirashima, Masanori
    Capoor, Seema
    Usui, Tomohiko
    Ambati, Balamurali K.
    Ambati, Jayakrishna
    [J]. NATURE MEDICINE, 2009, 15 (09) : 1023 - U74
  • [9] Interaction of tumor cells and lymphatic vessels in cancer progression
    Alitalo, A.
    Detmar, M.
    [J]. ONCOGENE, 2012, 31 (42) : 4499 - 4508
  • [10] The lymphatic vasculature in disease
    Alitalo, Kari
    [J]. NATURE MEDICINE, 2011, 17 (11) : 1371 - 1380